Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Sep 15, 2024; 16(9): 3955-3979
Published online Sep 15, 2024. doi: 10.4251/wjgo.v16.i9.3955
Published online Sep 15, 2024. doi: 10.4251/wjgo.v16.i9.3955
Measure of burden | Gender | Type of GI cancers | AAPC | P value | Trend 1 | Trend 2 | Trend 3 | Trend 4 | Trend 5 | Trend 6 | ||||||||||||
Years | APC | P value | Years | APC | P value | Years | APC | P value | Years | APC | P value | Years | APC | P value | Years | APC | P value | |||||
ASIR | Overall | Colon and rectum cancer | 3.00 | < 0.001 | 1990-1996 | -0.02 | 0.852 | 1996-2000 | 2.99 | < 0.001 | 2000-2004 | 7.64 | < 0.001 | 2014-2010 | 4.80 | < 0.001 | 2010-2016 | 1.00 | < 0.001 | 2016-2019 | 3.57 | < 0.001 |
Esophageal cancer | -2.08 | < 0.001 | 1990-1997 | -1.29 | < 0.001 | 1997-2004 | 2.40 | < 0.001 | 2004-2007 | -4.68 | < 0.001 | 2007-2014 | -6.37 | < 0.001 | 2014-2017 | -3.22 | < 0.001 | 2017-2019 | 0.83 | 0.129 | ||
Gallbladder and biliary tract cancer | 0.33 | 0.137 | 1990-1995 | -2.52 | < 0.001 | 1995-1998 | -1.275 | 0.236 | 1998-2001 | 4.62 | 0.001 | 2001-2014 | 7.719 | < 0.001 | 2014-2007 | 1.45 | 0.186 | 2007-2019 | -1.17 | < 0.001 | ||
Liver cancer | -3.35 | < 0.001 | 1990-1994 | 2.2 | < 0.001 | 1994-1998 | -2.12 | < 0.001 | 1998-2001 | -6.75 | < 0.001 | 2001-2005 | -17.96 | < 0.001 | 2005-2010 | -2.16 | < 0.001 | 2010-2019 | 1.36 | < 0.001 | ||
Pancreatic cancer | 1.43 | < 0.001 | 1990-1995 | -0.73 | < 0.001 | 1995-1998 | 1.48 | 0.06 | 1998-2004 | 3.48 | < 0.001 | 2004-2011 | 1.78 | < 0.001 | 2011-2016 | -0.15 | 0.512 | 2016-2019 | 2.85 | < 0.001 | ||
Stomach cancer | -1.05 | < 0.001 | 1990-1996 | -2.50 | < 0.001 | 1996-1999 | -0.03 | 0.967 | 1999-2004 | 4.00 | < 0.001 | 2004-2010 | -2.44 | < 0.001 | 2010-2016 | -3.34 | < 0.001 | 2016-2019 | 0.11 | 0.756 | ||
All GI cancers | -0.74 | < 0.001 | 1990-1993 | -0.20 | 0.558 | 1993-1998 | -1.11 | < 0.001 | 1998-2002 | -0.15 | 0.658 | 2002-2016 | -1.39 | < 0.001 | 2016-2019 | 1.61 | < 0.001 | N/A | N/A | N/A | ||
Female | Colon and rectum cancer | 1.77 | < 0.001 | 1990-1996 | -0.31 | 0.037 | 1996-2001 | 1.89 | < 0.001 | 2001-2004 | 4.72 | < 0.001 | 2014-2010 | 3.03 | < 0.001 | 2010-2016 | 0.16 | 0.399 | 2016-2019 | 3.67 | < 0.001 | |
Esophageal cancer | -3.63 | < 0.001 | 1990-1998 | -1.36 | < 0.001 | 1998-2004 | 2.40 | < 0.001 | 2004-2008 | -8.67 | < 0.001 | 2008-2013 | -10.57 | < 0.001 | 2013-2016 | -6.15 | < 0.001 | 2016-2019 | 0.17 | 0.81 | ||
Gallbladder and biliary tract cancer | -0.26 | 0.115 | 1990-1998 | -2.61 | < 0.001 | 1998-2001 | 4.169 | < 0.001 | 2001-2004 | 7.40 | < 0.001 | 2004-2007 | 0.13 | 0.888 | 2007-2014 | -2.31 | < 0.001 | 2014-2019 | -0.81 | 0.001 | ||
Liver cancer | -4.40 | < 0.001 | 1990-1995 | 0.06 | 0.826 | 1995-1998 | -3.90 | 0.006 | 1998-2001 | -7.45 | < 0.001 | 2001-2005 | -16.59 | < 0.001 | 2005-2011 | -3.56 | < 0.001 | 2011-2019 | -0.17 | 0.223 | ||
Pancreatic cancer | 0.96 | < 0.001 | 1990-1995 | -0.05 | 0.811 | 1995-1998 | 0.60 | 0.515 | 1998-2002 | 2.27 | < 0.001 | 2002-2007 | 1.23 | 0.001 | 2007-2016 | -0.01 | 0.892 | 2016-2019 | 3.83 | < 0.001 | ||
Stomach cancer | -2.04 | < 0.001 | 1990-1998 | -2.44 | < 0.001 | 1998-2004 | 1.35 | < 0.001 | 2004-2015 | -4.21 | < 0.001 | 2015-2019 | -0.19 | 0.399 | N/A | N/A | N/A | N/A | N/A | N/A | ||
All GI cancers | -1.29 | < 0.001 | 1990-1993 | -0.89 | 0.009 | 1993-1998 | -1.68 | < 0.001 | 1998-2003 | -0.40 | 0.049 | 2003-2013 | -2.54 | < 0.001 | 2013-2016 | -1.51 | 0.023 | 2016-2019 | 1.91 | < 0.001 | ||
Male | Colon and rectum cancer | 3.82 | < 0.001 | 1990-1996 | 0.17 | 0.183 | 1996-2000 | 4.04 | < 0.001 | 2000-2004 | 10.27 | < 0.001 | 2014-2011 | 5.39 | < 0.001 | 2011-2016 | 0.91 | 0.002 | 2016-2019 | 3.86 | < 0.001 | |
Esophageal cancer | -1.56 | < 0.001 | 1990-1997 | -1.12 | < 0.001 | 1997-2004 | 2.67 | < 0.001 | 2004-2007 | -3.35 | < 0.001 | 2007-2014 | -5.28 | < 0.001 | 2017-2017 | -3.13 | < 0.001 | 2017-2019 | 0.8 | 0.211 | ||
Gallbladder and biliary tract cancer | 0.90 | < 0.001 | 1990-1995 | -2.23 | < 0.001 | 1995-1998 | -0.42 | 0.596 | 1998-2001 | 5.48 | < 0.001 | 2001-2005 | 7.18 | < 0.001 | 2005-2010 | 0.64 | 0.021 | 2010-2019 | -0.93 | < 0.001 | ||
Liver cancer | -2.99 | < 0.001 | 1990-1994 | 2.71 | < 0.001 | 1994-1998 | -1.76 | < 0.001 | 1998-2001 | -6.38 | < 0.001 | 2001-2005 | -18.26 | < 0.001 | 2005-2010 | -1.55 | < 0.001 | 2010-2019 | 1.85 | < 0.001 | ||
Pancreatic cancer | 1.74 | < 0.001 | 1990-1995 | -1.19 | < 0.001 | 1995-1999 | 2.43 | < 0.001 | 1999-2004 | 4.65 | < 0.001 | 2004-2012 | 2.32 | < 0.001 | 2011-2016 | -0.53 | 0.23 | 2016-2019 | 2.52 | < 0.001 | ||
Stomach cancer | -0.60 | < 0.001 | 1990-1996 | -2.39 | < 0.001 | 1996-1999 | 0.43 | 0.587 | 1999-2004 | 5.16 | < 0.001 | 2004-2010 | -1.66 | < 0.001 | 2010-2016 | -3.12 | < 0.001 | 2016-2019 | -0.06 | 0.884 | ||
All GI cancers | -0.45 | < 0.001 | 1990-1992 | 0.51 | 0.45 | 1992-1998 | -0.78 | < 0.001 | 1998-2001 | 0.12 | 0.856 | 2001-2012 | -0.84 | < 0.001 | 2012-2016 | -1.25 | 0.002 | 2016-2019 | 1.56 | < 0.001 | ||
ASMR | Overall | Colon and rectum cancer | 0.52 | < 0.001 | 1990-1997 | -1.22 | < 0.001 | 1997-2000 | 1.71 | 0.009 | 2000-2004 | 4.69 | < 0.001 | 2004-2011 | 0.64 | < 0.001 | 2011-2016 | -1.56 | < 0.001 | 2016-2019 | 1.19 | 0.001 |
Esophageal cancer | -2.49 | < 0.001 | 1990-1998 | -1.26 | < 0.001 | 1998-2004 | 2.43 | < 0.001 | 2004-2007 | -5.55 | < 0.001 | 2007-2014 | -6.80 | < 0.001 | 2014-2017 | -3.63 | < 0.001 | 2017-2019 | 0.02 | 0.97 | ||
Gallbladder and biliary tract cancer | -0.01 | 0.951 | 1990-1995 | -2.73 | < 0.001 | 1995-1998 | -1.60 | 0.136 | 1998-2001 | 4.44 | 0.001 | 2001-2014 | 7.45 | < 0.001 | 2004-2007 | 0.93 | 0.379 | 2007-2019 | -1.57 | < 0.001 | ||
Liver cancer | -3.80 | < 0.001 | 1990-1996 | 1.11 | < 0.001 | 1996-2000 | -4.43 | < 0.001 | 2000-2004 | -18.45 | < 0.001 | 2004-2007 | -5.81 | 0.001 | 2007-2012 | -2.34 | < 0.001 | 2012-2019 | 1.51 | < 0.001 | ||
Pancreatic cancer | 1.38 | < 0.001 | 1990-1995 | -0.77 | < 0.001 | 1995-1998 | 1.41 | 0.07 | 1998-2004 | 3.49 | < 0.001 | 2004-2011 | 1.71 | < 0.001 | 2011-2016 | -0.23 | 0.325 | 2016-2019 | 2.76 | < 0.001 | ||
Stomach cancer | -2.66 | < 0.001 | 1990-1997 | -3.04 | 1997-2000 | 0.72 | 0.318 | 2000-2004 | 2.9 | 2004-2015 | -5.16 | < 0.001 | 2015-2019 | -2.91 | N/A | N/A | N/A | |||||
All GI cancers | -2.23 | < 0.001 | 1990-1993 | -0.63 | 0.01 | 1993-2000 | -1.46 | < 0.001 | 2000-2004 | -2.79 | < 0.001 | 2004-2014 | -3.66 | < 0.001 | 2014-2017 | -1.48 | 0.003 | 2017-2019 | -0.12 | 0.77 | ||
Female | Colon and rectum cancer | -0.72 | < 0.001 | 1990-1997 | -1.7 | < 0.001 | 1997-2001 | 0.13 | 0.712 | 2001-2004 | 1.67 | 0.037 | 2004-2011 | -0.98 | < 0.001 | 2011-2015 | -2.49 | < 0.001 | 2015-2019 | 0.61 | 0.018 | |
Esophageal cancer | -4.72 | < 0.001 | 1990-1998 | -2.23 | < 0.001 | 1998-2004 | 1.53 | 0.001 | 2004-2007 | -9.83 | < 0.001 | 2007-2013 | -11.69 | < 0.001 | 2013-2016 | -7 | 0.001 | 2016-2019 | -1.32 | 0.122 | ||
Gallbladder and biliary tract cancer | -0.65 | < 0.001 | 1990-1998 | -3.00 | < 0.001 | 1998-2001 | 3.93 | 0.001 | 2001-2004 | 7.26 | < 0.001 | 2004-2007 | -0.55 | 0.545 | 2007-2014 | -2.77 | < 0.001 | 2014-2019 | -1.17 | < 0.001 | ||
Liver cancer | -4.74 | < 0.001 | 1990-1996 | -0.31 | 0.087 | 1996-2000 | -5.65 | < 0.001 | 2000-2004 | -16.99 | < 0.001 | 2004-2007 | -6.39 | < 0.001 | 2007-2012 | -4.25 | < 0.001 | 2012-2019 | 0.04 | 0.771 | ||
Pancreatic cancer | 0.91 | < 0.001 | 1990-1997 | 0.01 | 0.962 | 1997-2006 | 1.81 | < 0.001 | 2006-2016 | -0.09 | 0.381 | 2016-2019 | 3.75 | < 0.001 | N/A | N/A | N/A | N/A | N/A | N/A | ||
Stomach cancer | -3.48 | < 0.001 | 1990-1998 | -3.13 | < 0.001 | 1998-2004 | 0.39 | 0.011 | 2004-2014 | -6.42 | < 0.001 | 2014-2019 | -2.58 | < 0.001 | N/A | N/A | N/A | N/A | N/A | N/A | ||
All GI cancers | -2.93 | < 0.001 | 1990-1993 | -1.39 | 0.001 | 1993-2004 | -2.36 | < 0.001 | 2004-2013 | -5.21 | < 0.001 | 2013-2016 | -2.31 | 0.003 | 2016-2019 | -0.25 | 0.455 | N/A | N/A | N/A | ||
Male | Colon and rectum cancer | 1.32 | < 0.001 | 1990-1996 | -0.99 | < 0.001 | 1996-1999 | 1.23 | 0.036 | 1999-2004 | 6.53 | < 0.001 | 2004-2011 | 1.66 | < 0.001 | 2011-2016 | -1.25 | < 0.001 | 2016-2019 | 1.15 | 0.001 | |
Esophageal cancer | -1.89 | < 0.001 | 1990-1997 | -1.23 | < 0.001 | 1997-2004 | 2.42 | < 0.001 | 2004-2007 | -3.86 | < 0.001 | 2007-2014 | -5.73 | < 0.001 | 2014-2017 | -3.49 | < 0.001 | 2017-2019 | 0.14 | 0.819 | ||
Gallbladder and biliary tract cancer | 0.61 | < 0.001 | 1990-1995 | -2.31 | < 0.001 | 1995-1998 | -0.60 | 0.449 | 1998-2001 | 5.31 | < 0.001 | 2001-2005 | 6.8 | < 0.001 | 2005-2010 | 0.25 | 0.325 | 2010-2019 | -1.33 | < 0.001 | ||
Liver cancer | -3.47 | < 0.001 | 1990-1996 | 1.66 | < 0.001 | 1996-2000 | -4.57 | < 0.001 | 2000-2005 | -17.1 | < 0.001 | 2005-2012 | -1.84 | < 0.001 | 2012-2019 | 1.92 | < 0.001 | N/A | N/A | N/A | ||
Pancreatic cancer | 1.69 | < 0.001 | 1990-1995 | -1.21 | < 0.001 | 1995-1999 | 2.41 | < 0.001 | 1999-2004 | 4.63 | < 0.001 | 2004-2012 | 2.25 | < 0.001 | 2012-2016 | -0.61 | 0.164 | 2016-2019 | 2.43 | < 0.001 | ||
Stomach cancer | -2.26 | < 0.001 | 1990-1996 | -3.02 | < 0.001 | 1996-1999 | -0.43 | 0.652 | 1999-2004 | 3.6 | < 0.001 | 2004-2008 | -4.01 | < 0.001 | 2008-2015 | -4.97 | < 0.001 | 2015-2019 | -3.02 | < 0.001 | ||
All GI cancers | -1.92 | < 0.001 | 1990-1993 | -0.34 | 0.436 | 1993-2000 | -1.01 | < 0.001 | 2000-2015 | -2.96 | < 0.001 | 2015-2019 | -0.75 | 0.011 | N/A | N/A | N/A | N/A | N/A | N/A | ||
ASDR | Overall | Colon and rectum cancer | 0.59 | < 0.001 | 1990-1997 | -0.99 | < 0.001 | 1997-2000 | 1.71 | 0.002 | 2000-2004 | 4.09 | < 0.001 | 2004-2011 | 0.67 | < 0.001 | 2011-2016 | -1.29 | < 0.001 | 2016-2019 | 1.55 | < 0.001 |
Esophageal cancer | -2.53 | < 0.001 | 1990-1997 | -1.43 | < 0.001 | 1997-2004 | 1.99 | < 0.001 | 2004-2007 | -5.58 | < 0.001 | 2007-2014 | -6.98 | < 0.001 | 2014-2017 | -3.48 | < 0.001 | 2017-2019 | 0.21 | 0.71 | ||
Gallbladder and biliary tract cancer | -0.02 | 0.895 | 1990-1998 | -2.23 | < 0.001 | 1998-2001 | 4.58 | < 0.001 | 2001-2004 | 6.58 | < 0.001 | 2004-2007 | 0.98 | 0.167 | 2007-2015 | -1.74 | < 0.001 | 2015-2019 | -0.97 | < 0.001 | ||
Liver cancer | -3.77 | < 0.001 | 1990-1996 | 1.17 | < 0.001 | 1996-2000 | -4.55 | < 0.001 | 2000-2004 | -18.41 | < 0.001 | 2004-2007 | -5.82 | 0.001 | 2007-2012 | -2.31 | < 0.001 | 2012-2019 | 1.6 | < 0.001 | ||
Pancreatic cancer | 1.37 | < 0.001 | 1990-1995 | -0.72 | 0.001 | 1995-1998 | 1.67 | 0.044 | 1998-2004 | 3.27 | < 0.001 | 2004-2011 | 1.63 | < 0.001 | 2011-2016 | -0.17 | 0.477 | 2016-2019 | 2.88 | < 0.001 | ||
Stomach cancer | -2.61 | < 0.001 | 1990-1997 | -2.89 | < 0.001 | 1997-2000 | 0.89 | 0.15 | 2000-2004 | 2.51 | < 0.001 | 2004-2015 | -5.17 | < 0.001 | 2015-2019 | -2.56 | < 0.001 | N/A | N/A | N/A | ||
All GI cancers | -2.22 | < 0.001 | 1990-1994 | -0.66 | 0.002 | 1994-2000 | -1.46 | < 0.001 | 2000-2005 | -3.33 | < 0.001 | 2005-2013 | -3.70 | < 0.001 | 2013-2016 | -1.97 | 0.002 | 2016-2019 | -0.17 | 0.535 | ||
Female | Colon and rectum cancer | -0.68 | < 0.001 | 1990-1996 | -1.22 | < 0.001 | 1996-2005 | -0.08 | 0.108 | 2005-2011 | -0.98 | < 0.001 | 2011-2015 | -2.21 | < 0.001 | 2015-2019 | 0.78 | < 0.001 | N/A | N/A | N/A | |
Esophageal cancer | -4.70 | < 0.001 | 1990-1998 | -1.80 | < 0.001 | 1998-2004 | 1.19 | 0.001 | 2004-2007 | -10.13 | < 0.001 | 2007-2013 | -11.76 | < 0.001 | 2013-2016 | -6.92 | < 0.001 | 2016-2019 | -1.2 | 0.081 | ||
Gallbladder and biliary tract cancer | -0.73 | < 0.001 | 1990-1998 | -2.59 | < 0.001 | 1998-2001 | 3.49 | < 0.001 | 2001-2004 | 5.87 | < 0.001 | 2004-2007 | -0.74 | 0.308 | 2007-2014 | -2.8 | < 0.001 | 2014-2019 | -1.12 | < 0.001 | ||
Liver cancer | -4.77 | < 0.001 | 1990-1996 | 0.19 | 0.214 | 1996-2000 | -5.50 | < 0.001 | 2000-2004 | -17.77 | < 0.001 | 2004-2007 | -6.54 | < 0.001 | 2007-2012 | -4.27 | < 0.001 | 2012-2019 | 0.03 | 0.83 | ||
Pancreatic cancer | 0.85 | < 0.001 | 1990-1997 | 0.27 | 0.042 | 1997-2001 | 1.91 | 0.001 | 2001-2007 | 0.84 | 0.001 | 2007-2016 | -0.11 | 0.28 | 2016-2019 | 3.73 | < 0.001 | N/A | N/A | N/A | ||
Stomach cancer | -3.44 | < 0.001 | 1990-1997 | -2.79 | < 0.001 | 1997-2004 | -0.59 | < 0.001 | 2004-2014 | -6.31 | < 0.001 | 2014-2019 | -2.41 | < 0.001 | N/A | N/A | N/A | N/A | N/A | N/A | ||
All GI cancers | -2.91 | < 0.001 | 1990-1994 | -1.31 | < 0.001 | 1994-2000 | -1.92 | < 0.001 | 2000-2004 | -3.77 | < 0.001 | 2004-2013 | -5.03 | < 0.001 | 2013-2016 | -2.18 | 0.001 | 2016-2019 | -0.13 | 0.601 | ||
Male | Colon and rectum cancer | 1.38 | < 0.001 | 1990-1996 | -1.03 | < 0.001 | 1996-1999 | 1.18 | 0.053 | 1999-2004 | 6.46 | < 0.001 | 2004-2011 | 1.64 | < 0.001 | 2011-2016 | -0.99 | < 0.001 | 2016-2019 | 1.59 | < 0.001 | |
Esophageal cancer | -1.93 | < 0.001 | 1990-1997 | -1.18 | < 0.001 | 1997-2004 | 2.45 | < 0.001 | 2004-2007 | -4.15 | < 0.001 | 2007-2014 | -5.95 | < 0.001 | 2014-2017 | -3.34 | < 0.001 | 2017-2019 | 0.35 | 0.572 | ||
Gallbladder and biliary tract cancer | 0.53 | < 0.001 | 1990-1995 | -2.49 | < 0.001 | 1995-1998 | -0.82 | 0.304 | 1998-2001 | 4.94 | < 0.001 | 2001-2004 | 7.62 | < 0.001 | 2004-2008 | 1.66 | 0.001 | 2008-2019 | -1.13 | < 0.001 | ||
Liver cancer | -3.44 | < 0.001 | 1990-1996 | 1.59 | < 0.001 | 1996-2000 | -4.74 | < 0.001 | 2000-2005 | -16.87 | < 0.001 | 2005-2012 | -1.84 | < 0.001 | 2012-2019 | 2.00 | < 0.001 | N/A | N/A | N/A | ||
Pancreatic cancer | 1.71 | < 0.001 | 1990-1995 | -1.25 | < 0.001 | 1995-1999 | 2.47 | < 0.001 | 1999-2004 | 4.66 | < 0.001 | 2004-2012 | 2.17 | < 0.001 | 2012-2016 | -0.49 | < 0.001 | 2016-2019 | 2.63 | < 0.001 | ||
Stomach cancer | -2.21 | < 0.001 | 1990-1996 | -3.03 | < 0.001 | 1996-1999 | -0.26 | 0.751 | 1999-2004 | 3.67 | < 0.001 | 2004-2008 | -4.17 | < 0.001 | 2008-2015 | -4.99 | < 0.001 | 2015-2019 | -2.66 | < 0.001 | ||
All GI cancers | -1.91 | < 0.001 | 1990-1993 | -0.15 | 0.699 | 1993-2000 | -1.13 | < 0.001 | 2000-2014 | -3.07 | < 0.001 | 2004-2019 | -0.79 | < 0.001 | N/A | N/A | N/A | N/A | N/A | N/A |
- Citation: Dong Y, Fan ZZ, Li WT, Kang J, Zhang Y, Guan Y, Xu HQ, Yuan J, Xu F. Burden of gastrointestinal cancers among working-age population over past thirty years in China. World J Gastrointest Oncol 2024; 16(9): 3955-3979
- URL: https://www.wjgnet.com/1948-5204/full/v16/i9/3955.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i9.3955